After signing up, you'll start to receive regular news updates from us.
Proteus Granted U.S. Patent on Gene Shuffling Technology
Complete the form below to unlock access to ALL audio articles.
Proteus has announced that it has been granted U.S. Patent No. 6,951,719 for L-Shuffling™, a gene shuffling technology developed by Proteus to generate and optimize proteins for commercial product applications.
This L-Shuffling™ recombination-based protein engineering technology dramatically accelerates the development of new or improved products and processes.
L-Shuffling™'s growing list of applications include developing therapeutic proteins, industrial biocatalysts and agricultural traits optimization.
The new patent broadly covers Proteus in vitro gene shuffling recombination methods in a variety of embodiments, and contains multiple claims covering ligation-mediated in vitro recombination methods.
“Getting the protein you have been dreaming of is what L-Shuffling™ provides,” said Daniel Dupret, President and CEO of Proteus. “The issuance of this new patent reinforces Proteus leadership in this field of biotechnology.”
